Related Experiment Videos
Understanding and preventing drug interactions in elderly patients
1Virginia Commonwealth University School of Pharmacy, P.O. Box 980533, 410 N. 12th Street, Room 454, Richmond, VA 23298-0533, USA. jeff.delafuente@vcu.edu
Critical Reviews in Oncology/Hematology
|November 11, 2003
Summary
Elderly individuals often experience dangerous drug-drug interactions due to polypharmacy and physiological changes. Vigilant medication monitoring is crucial to prevent adverse events and declining functional abilities in older adults.
Area of Science:
- Gerontology
- Clinical Pharmacology
- Pharmacoepidemiology
Background:
- Older adults consume a high volume of prescription and nonprescription drugs.
- Physiological changes, polypharmacy, and multiple prescribers increase drug interaction risks in the elderly.
- Drug interactions are linked to emergency room visits, physician consultations, and functional decline in older populations.
Purpose of the Study:
- To highlight the significant risk of clinically significant drug-drug interactions in the elderly population.
- To underscore the impact of drug interactions on morbidity and functional status in older individuals.
- To emphasize the importance of medication management in preventing adverse drug events.
Main Methods:
- Review of existing literature on drug interactions in the elderly.
- Analysis of factors contributing to increased risk, including polypharmacy and altered physiology.
- Examination of the pharmacokinetic and pharmacodynamic consequences of drug interactions.
Main Results:
- The incidence of potential drug-drug interactions escalates with increased medication use in the elderly.
- Drug interactions can alter drug absorption, distribution, metabolism, or excretion, affecting pharmacodynamics.
- Many drug interactions in the elderly remain clinically unrecognized, contributing to increased morbidity.
Conclusions:
- Drug-drug interactions pose a substantial threat to the health and well-being of the elderly.
- Effective medication management and diligent monitoring are essential to mitigate these risks.
- Proactive strategies are needed to prevent adverse drug events and improve patient outcomes in older adults.